Clinical Trial Update: Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of AL-60371 Otic Suspension 0.3% for acute otitis externa; the study completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Externa

Drugs mentioned

• AL-60371 Otic Suspension, 0.3%

Snippet

Sponsor: Alcon Research | Conditions: Acute Otitis Externa | Phase 3 | Status: COMPLETED | Results posted: 2014-06-18